Peptide Lab HQ Research Guide
BPC-157
A research-focused compound profile covering BPC-157 identity, tissue-response research, gastric peptide models, concentration reference, reconstitution reference, and safety considerations.
Compound Data
Compound Profile
| Compound Name | BPC-157 |
|---|---|
| Compound Type | Synthetic pentadecapeptide |
| CAS Number | 137525-51-0 |
| Amino Acid Length | 15 amino acids |
| Amino Acid Sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Short Sequence | GEPPPGKPADDAGLV |
| Molecular Formula | C₆₂H₉₈N₁₆O₂₂ |
| Molecular Weight | 1419.54 g/mol |
| Appearance | White to off-white lyophilized powder |
| Use | For laboratory research use only. |
Research Applications
Key Research Applications
BPC-157 is commonly discussed in controlled research models involving gastric peptide signaling, tissue-response pathways, tendon and ligament models, angiogenesis-related observations, and cellular migration research.
Gastric Peptide Research
BPC-157 is frequently discussed in research involving gastric peptide fragments and protective signaling models related to gastrointestinal research settings.
Tissue-Response Models
Used in controlled research settings examining tissue-response signaling, cellular migration, and repair-associated pathways.
Tendon & Ligament Studies
Appears in preclinical research models involving tendon, ligament, and musculoskeletal tissue-response observations.
Angiogenesis Research
Studied in models involving vascular-response signaling, endothelial behavior, and angiogenesis-related pathways.
Cellular Migration Models
Relevant to research involving fibroblast behavior, cell migration, collagen-associated observations, and localized repair signaling.
Preclinical Study Models
Most BPC-157 research discussion is based on laboratory, animal, and preclinical study models rather than approved human-use applications.
Research Scope
These applications are provided for educational and research-reference purposes only. Research outcomes may vary based on study model, compound form, concentration, purity, route used in preclinical studies, and laboratory conditions.
Reference Only
Reconstitution / Research Dosing Reference
Select Reference Vial
Select a vial size to update the concentration, U-100 unit references, and frequency table below.
Quick Reference Summary
| Reference Vial | 2 mg BPC-157 |
|---|---|
| Primary Solution Volume | 2.0 mL bacteriostatic water |
| Primary Concentration | 1 mg/mL |
| Measurement Reference | On a U-100 syringe, 1 unit = 0.01 mL. |
| Amount per U-100 Unit | At 1 mg/mL, 1 unit equals 0.01 mg / 10 mcg BPC-157. |
| Storage Reference | Refrigerate at 2–8°C / 35.6–46.4°F after reconstitution, protected from direct light. |
Reconstitution Steps
- Draw 2.0 mL bacteriostatic water using a sterile syringe for the main concentration reference shown below.
- Slowly add the BAC water down the side of the vial wall.
- Gently roll or swirl the vial until the material is completely dissolved. The solution should appear clear to slightly hazy depending on concentration and supplier format. Do not shake!
- For higher-concentration preparations, verify that the material is fully dissolved before recording the final preparation details.
- Label with compound name, vial amount, concentration, solvent volume, preparation date, storage conditions, and handling notes.
- Store refrigerated at 2–8°C / 35.6–46.4°F, protected from direct light.
Published Research Context
| Reference Type | Reported Amount / Context | Research Notes |
|---|---|---|
| Compound Identity Reference | BPC-157, stable gastric pentadecapeptide | BPC-157 is commonly discussed as a 15-amino-acid peptide fragment associated with gastric peptide, tissue-response, and cytoprotective research contexts. |
| Sequence Reference | GEPPPGKPADDAGLV | This sequence is commonly listed in BPC-157 chemical database and literature references. |
| Gastrointestinal Research Context | Experimental and model-dependent context | BPC-157 is frequently discussed in gastric, intestinal, epithelial-barrier, mucosal-response, and gastrointestinal tissue-response research models. |
| Tissue-Response Research Context | Model-dependent concentration and endpoint tracking | Commonly discussed in tendon, ligament, muscle, connective-tissue, wound-healing, and recovery-model research contexts. |
| Angiogenesis / Vascular Research | Experimental marker and pathway context | Research discussions often include angiogenesis-marker, endothelial-response, nitric-oxide pathway, vascular-response, and tissue-repair marker observations. |
| Inflammatory-Marker Research | Preclinical and model-dependent context | BPC-157-related research commonly includes inflammatory-marker response, oxidative-stress context, cellular-protection markers, and tissue-integrity observations. |
| Public Protocol-Style Reference | Microgram-to-milligram reference examples | Public protocol-style references commonly describe BPC-157 in microgram-to-milligram examples depending on the research model and preparation format. These are not clinical dosing standards. |
| Clinical / Research-Chemical Status | No universal research-chemical protocol established | Published study references, preclinical references, public protocol-style references, or wellness protocols should not be treated as dosing instructions for research-chemical vial formats. |
Concentration Reference
| Vial Amount | Solution Volume | Final Concentration |
|---|---|---|
| 2 mg | 2.0 mL | 1 mg/mL |
| 5 mg | 2.0 mL | 2.5 mg/mL |
| 20 mg | 3.0 mL | 6.67 mg/mL |
Research Dosing Amount / Volume Reference
| Reference Amount | Volume at 1 mg/mL | U-100 Unit Reference | Approx. References per 2 mg Vial |
|---|---|---|---|
| 50 mcg | 0.05 mL | 5 units | 40 |
| 0.1 mg / 100 mcg | 0.10 mL | 10 units | 20 |
| 0.25 mg / 250 mcg | 0.25 mL | 25 units | 8 |
| 0.5 mg / 500 mcg | 0.50 mL | 50 units | 4 |
| 1 mg / 1000 mcg | 1.00 mL | 100 units | 2 |
| 2 mg / 2000 mcg | 2.00 mL | 200 units | 1 |
| 5 mg / 5000 mcg | 5.00 mL | 500 units | 0.4 |
| 10 mg / 10000 mcg | 10.00 mL | 1000 units | 0.2 |
| 20 mg / 20000 mcg | 20.00 mL | 2000 units | 0.1 |
Research Frequency / Amount Reference
| Research Window | Frequency | Reference Amount | Units / Volume Reference |
|---|---|---|---|
| Lower Microgram Reference | Calculation reference only | 50 mcg reference amount | 5 units / 0.05 mL |
| Standard Microgram Reference | Calculation reference only | 0.1 mg reference amount | 10 units / 0.10 mL |
| Low Milligram Conversion Example | Public protocol-style reference, not a clinical dosing standard | 250 mcg reference amount | 25 units / 0.25 mL |
| Mid-Range Conversion Example | Public protocol-style reference, not a clinical dosing standard | 0.5 mg reference amount | 50 units / 0.50 mL |
| Upper Conversion Example | Calculation reference only | 1 mg reference amount | 100 units / 1.00 mL |
| 2 mg Preparation Reference | Preparation-level calculation reference | 2 mg reference amount | 200 units / 2.00 mL |
| 5 mg Preparation Reference | Preparation-level calculation reference | 5 mg reference amount | 500 units / 5.00 mL |
| 10 mg Preparation Reference | Preparation-level calculation reference | 10 mg reference amount | 1000 units / 10.00 mL |
| 20 mg Preparation Reference | Preparation-level calculation reference | 20 mg reference amount | 2000 units / 20.00 mL |
Common Research Windows
| Reference Window | Common Length | Research Notes |
|---|---|---|
| Cell-Culture / Marker Observation Window | 24–72 hours | May be used for cell-migration, angiogenesis-marker, inflammatory-marker, epithelial-response, fibroblast-response, or peptide-response documentation depending on the model. |
| Acute Tissue-Response Window | Single session to several days | Used for short-term tissue-response marker comparison, inflammatory-marker observation, vascular-response tracking, or early pathway documentation depending on the research design. |
| Short Research Window | 1–4 weeks | May be used for early controlled observation involving gastrointestinal, connective-tissue, tendon, ligament, muscle, or recovery-model endpoints. |
| Standard Protocol-Style Window | 4–8 weeks | Commonly used in public protocol-style references for structured observation and comparison across baseline and follow-up periods. |
| Extended Observation Window | 8–12 weeks or longer | Used when longer documentation is needed for tissue-response trends, angiogenesis-marker comparison, connective-tissue markers, inflammatory-marker tracking, or follow-up marker documentation. |
| Follow-Up / Washout | 2–8 weeks | Used to document post-study observations, marker return, delayed response patterns, or follow-up data depending on the research model. |
Research Note: These tables are provided for educational, research-planning, concentration, frequency-reference, and volume-reference purposes only. BPC-157 is commonly discussed in stable gastric pentadecapeptide, gastrointestinal, tissue-response, connective-tissue, tendon, ligament, angiogenesis, inflammatory-marker, nitric-oxide pathway, wound-healing, and recovery-model research contexts. The selector above updates calculations for 2 mg and 5 mg vial references reconstituted with 2.0 mL bacteriostatic water, and a 20 mg vial reference reconstituted with 3.0 mL bacteriostatic water. Published study references, preclinical research references, and public protocol-style frequency references are not universal research-chemical dosing standards and should not be treated as dosing instructions for research-chemical vial formats. This information is not medical advice, dosing instruction, injectable-use guidance, or a recommendation for human or animal use.
Research Notes
Research Findings & Safety Notes
Research Findings
BPC-157 is commonly discussed in research involving stable gastric peptide activity, gastrointestinal tissue response, tendon and ligament models, muscle injury models, wound-healing observations, angiogenesis context, nitric-oxide pathway interaction, and nerve-response research.
Study Limitations
BPC-157 research is primarily preclinical. Human clinical data remains limited, and animal or in-vitro findings should not be treated as established human safety or efficacy conclusions.
Safety Considerations
Research discussion should account for peptide identity verification, impurity profile, immunogenicity risk, angiogenesis-related uncertainty, route-specific uncertainty, sterility documentation, endotoxin risk, storage conditions, and qualified laboratory handling procedures.
Use Restriction
Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease when discussed as a research-use material.
Related Supplies
Research Supplies
For research supplies, visit our affiliate partner and use code PLHQ10 to save 10% on your order.
Bacteriostatic Water
Commonly referenced in laboratory preparation workflows.
Research Syringes
Supply category for controlled laboratory research preparation.
Prep Supplies
Supporting supplies for clean handling, preparation, and documentation.
Lab Handling
Handling & Storage
Storage
Store lyophilized material according to product-specific documentation. Protect from excessive heat, moisture, and direct light.
After Reconstitution
Keep refrigerated after reconstitution unless otherwise specified by the product documentation.
Handling
Use appropriate laboratory PPE, clean handling practices, and qualified research procedures.
Documentation
Maintain batch details, COA records, preparation notes, and internal research documentation.